Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults (original) (raw)
References
Barnum SR, Volanakis JE (1989). Structure and function of C3. Year Immunol6, 208–228. PubMed Google Scholar
Benatar SR (2004). Linking moral progress to medical progress: new opportunities for the Declaration of Helsinki. World Med J50: 11–13. Google Scholar
Bleys J, Navas-Acien A, Stranges S, Menke A, Miller III ER, Guallar E (2008). Serum selenium and serum lipids in US adults. Am J Clin Nutr88, 416–423. ArticleCAS Google Scholar
Brenneisen P, Steinbrenner H, Sies H (2005). Selenium, oxidative stress, and health aspects. Mol Aspects Med26, 256–267. ArticleCAS Google Scholar
Bykov I, Junnikkala S, Pekna M, Lindros KO, Meri S (2006). Complement C3 contributes to ethanol-induced liver steatosis in mice. Ann Med38, 280–286. ArticleCAS Google Scholar
Choy LN, Rosen BS, Spiegelman BM (1992). Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem267, 12736–12741. CASPubMed Google Scholar
Cianflone K, Xia Z, Chen LY (2003). Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta1609, 127–143. ArticleCAS Google Scholar
Dandona P, Aljada A, Bandyopadhyay A (2004). Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol25, 4–7. ArticleCAS Google Scholar
Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005). Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation111, 1448–1454. Article Google Scholar
Engstrom G, Hedblad B, Janzon L, Lindgarde F (2005a). Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study. Diabetologia48, 2525–2531. ArticleCAS Google Scholar
Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F (2005b). Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes54, 570–575. Article Google Scholar
Ferencik M, Ebringer L (2003). Modulatory effects of selenium and zinc on the immune system. Folia Microbiol (Praha)48, 417–426. ArticleCAS Google Scholar
Friedewald WT, Levy RI, Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem18, 499–502. CAS Google Scholar
Fulop T, Tessier D, Carpentier A (2006). The metabolic syndrome. Pathol Biol (Paris)54, 375–386. ArticleCAS Google Scholar
Gabrielsson BG, Johansson JM, Lonn M, Jernas M, Olbers T, Peltonen M et al. (2003). High expression of complement components in omental adipose tissue in obese men. Obes Res11, 699–708. ArticleCAS Google Scholar
Ghayour-Mobarhan M, Taylor A, New SA, Lamb DJ, Ferns GA (2005). Determinants of serum copper, zinc and selenium in healthy subjects. Ann Clin Biochem42, 364–375. ArticleCAS Google Scholar
Gibson RS (2005). Principles of Nutritional Assessment. Oxford University Press: New York. Google Scholar
Halkes CJ, van Dijk H, de Jaegere PP, Plokker HW, van Der Helm Y, Erkelens DW et al. (2001). Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol21, 1526–1530. ArticleCAS Google Scholar
Hsieh SD, Muto T (2005). The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med40, 216–220. Article Google Scholar
Hsieh SD, Yoshinaga H, Muto T (2003). Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord27, 610–616. ArticleCAS Google Scholar
Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, Stampfer MJ et al. (1990). Predictors of selenium concentration in human toenails. Am J Epidemiol132, 114–122. ArticleCAS Google Scholar
Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA et al. (2001). Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol21, 1034–1039. ArticleCAS Google Scholar
Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA et al. (2004). Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care27, 2033–2040. ArticleCAS Google Scholar
Maehira F, Luyo GA, Miyagi I, Oshiro M, Yamane N, Kuba M et al. (2002). Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clin Chim Acta316, 137–146. ArticleCAS Google Scholar
Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D et al. (1999). Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest29, 679–686. ArticleCAS Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentrations in men. Diabetologia28, 412–419. ArticleCAS Google Scholar
Moreno-Aliaga MJ, Campión J, Milagro FI, Berjón A, Martínez JA (2005). Adiposity and proinflammatory state: the chicken or the egg. Adipocytes1, 1–16. Google Scholar
Muscari A, Sbano D, Bastagli L, Poggiopollini G, Tomassetti V, Forti P et al. (2005). Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction. Int J Cardiol100, 217–223. Article Google Scholar
Musil F, Zadak Z, Solichova D, Hyspler R, Kaska M, Sobotka L et al. (2005). Dynamics of antioxidants in patients with acute pancreatitis and in patients operated for colorectal cancer: a clinical study. Nutrition21, 118–124. ArticleCAS Google Scholar
Onat A, Uzunlar B, Hergenc G, Yazici M, Sari I, Uyarel H et al. (2005). Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (London)108, 129–135. ArticleCAS Google Scholar
Sahu A, Lambris JD (2001). Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev180, 35–48. ArticleCAS Google Scholar
Sampietro T, Bigazzi F, Dal Pino B, Rossi G, Chella E, Lusso S et al. (2004). Upregulation of C3, C4, and soluble intercellular adhesion molecule-1 co-expresses with high sensitivity C reactive protein in familial hypoalphalipoproteinaemia: further evidence of inflammatory activation. Heart90, 1438–1442. ArticleCAS Google Scholar
Satia JA, King IB, Morris JS, Stratton K, White E (2006). Toenail and plasma levels as biomarkers of selenium exposure. Ann Epidemiol16, 53–58. Article Google Scholar
Savoia C, Schiffrin EL (2007). Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (London)112, 375–384. ArticleCAS Google Scholar
Scheurig AC, Thorand B, Fischer B, Heier M, Koenig W (2007). Association between the intake of vitamins and trace elements from supplements and C-reactive protein: results of the MONICA/KORA Augsburg study. Eur J Clin Nutr62, 127–137. Article Google Scholar
Sniderman AD, Maslowska M, Cianflone K (2000). Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol11, 291–296. ArticleCAS Google Scholar
van Oostrom AJ, Alipour A, Plokker TW, Sniderman AD, Cabezas MC (2007). The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis190, 167–173. ArticleCAS Google Scholar
Vincent HK, Taylor AG (2006). Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes (London)30, 400–418. ArticleCAS Google Scholar
Warnberg J, Nova E, Moreno LA, Romeo J, Mesana MI, Ruiz JR et al. (2006). Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr84, 505–512. ArticleCAS Google Scholar
Ylitalo K, Pajukanta P, Meri S, Cantor RM, Mero-Matikainen N, Vakkilainen J et al. (2001). Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol21, 838–843. ArticleCAS Google Scholar
Yudkin JS (2000). Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent? Eur Heart J21, 1036–1039. ArticleCAS Google Scholar